We cannot sit still and wait for death. We must act extremely quickly.

Today, SOSV announced that we are providing millions of dollars in additional immediate funding to life sciences entrepreneurs working on novel solutions to the COVID-19 pandemic (IndieBio will fund up to eight over the next six weeks COVID-19 startups).

We have teams and staff in place who are working tirelessly to help. Scientists, doctors, entrepreneurs, investors. What’s more, we’ve supported hundreds of deep tech startups over the past eight years who are turning their sights on COVID-19.

We are helping them meet their challenges with necessary emergency funding. We may invest approximately $10 million in response to COVID-19 in the coming months, and investors in our syndicate may invest an additional $50 million.

Startups are already battling the virus.

A dozen startups in our portfolio are literally on the front lines of the COVID-19 response, working on diagnostics, treatments, prevention and disinfection technologies, test automation, and some just improving the daily lives of those trapped at home. Here’s a quick look at some of them:

• renegade bio將 CDC COVID-19 測試的 4 個步驟減少到 1 個品率，從而減少了 2 個小時的測試過程應用的因素之一，將成本降低了一半，并將 qPCR 測試的通量提高了 4 倍指導。
• CAS PR.bio正急于推出一種基于“Crispr Cas12”的診斷測試，該測試足夠便宜且易于操作充分，適合辦公室或家庭使用進一步完善，并可在 1 小時內報告結果。
• verX開發(fā)了一種納米纖維材料競爭力，可為護理人員制造更透氣調整推進、更安全的口罩。
• OACP的試劑比美國 FDA/CDC 試劑快 20%機製性梗阻，價格便宜機製，而且數(shù)量充足。
• open TR ONS擁有一款適用于中小型實驗室的液體處理機器人集成應用，可以自動執(zhí)行測試探討，以便每天在任何地方的醫(yī)院進行數(shù)千次測試。
• you i bot擁有消毒和檢查機器人高效流通，可以部署在公共區(qū)域或工作場所調解製度。
• str ADO is提供了一種慢性阻塞性肺病反饋監(jiān)測系統(tǒng)，能夠自動向醫(yī)生報告異常的肺部活動有效性。

Through our accelerator programs – HAX, IndieBio, Chinaccelerator, MOX, Food-X and dlab – we support passionate entrepreneurs who want to make the world a better place. We are deeply grateful for their efforts, their ingenuity, and the dedication in their hearts to solve some of the world's most difficult and pressing problems.

If you or someone you know needs funding for a life sciences startup providing COVID-19 solutions, apply by April 10 at indiebio.co/indiebio-covid-response.

Through IndieBio, we support entrepreneurs who want to use biological technologies to solve humanity's biggest and most pressing problems. Now, let's keep working together to find solutions.